| |
|
|
 |
 |
 |
 |
 |
|
Susan Greenfield is one of Britain’s most influential yet unconventional scientists. Her ambition is to make science accessible as well as glamorous and exciting.
Currently professor of pharmacology at Oxford University and a fellow in medicine at Oxford’s Lincoln College, Greenfield is renowned for her groundbreaking studies of the brain and human consciousness.
In 1997, she co-founded the biotechnology firm Synaptica, with a goal of finding a drug to treat Alzheimer’s and Parkinson’s disease. "My view is that the two share common factors," says Greenfield, who is currently conducting research into a brain molecule that could hold the key to curing these neurodegenerative disorders.
Selected in 1998 as the first woman director of the venerable Royal Institution – Britain’s 200-year-old-research institute – Greenfield sees this appointment as an opportunity to create a lively forum for scientific learning and debate. "I’d like to see young scientists coming to the institute to discuss, lobby and argue," she comments.
A recipient of many honours, Professor Greenfield was awarded the Royal Society’s Michael Faraday medal in 1998 for her significant contribution to the public understanding of science. The high-profile neuroscientist is widely known for her books on the brain, including the best seller, "The Human Brain: A Guided Tour", and for her newspaper column and TV appearances. Her most recent venture is a BBC television series on the brain and the mind. |
|
|
|
